Ixekizumab for the treatment of patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors: results from the 24-week …
Background Patients who have had inadequate response to tumour necrosis factor
inhibitors have fewer treatment options and are generally more treatment refractory to …
inhibitors have fewer treatment options and are generally more treatment refractory to …
[PDF][PDF] Sarilumab plus methotrexate in patients with active rheumatoid arthritis and inadequate response to methotrexate: results of a phase III study
…, AJ Kivitz, M Rell‐Bakalarska… - Arthritis & …, 2015 - Wiley Online Library
Objective To evaluate the efficacy and safety of sarilumab in combination with methotrexate
(MTX) for the treatment of rheumatoid arthritis (RA). Methods Adults with moderate‐to …
(MTX) for the treatment of rheumatoid arthritis (RA). Methods Adults with moderate‐to …
High levels of osteoprotegerin and soluble receptor activator of nuclear factor κB ligand in serum of rheumatoid arthritis patients and their normalization after anti …
…, J Kowalczewski, M Rell‐Bakalarska… - … : Official Journal of …, 2002 - Wiley Online Library
Objective To test the hypotheses that 1) proinflammatory cytokines affect osteoprotegerin
(OPG) and soluble receptor activator of nuclear factor κB ligand (sRANKL) production and …
(OPG) and soluble receptor activator of nuclear factor κB ligand (sRANKL) production and …
[PDF][PDF] Phase III Randomized Study of SB 5, an Adalimumab Biosimilar, Versus Reference Adalimumab in Patients With Moderate‐to‐Severe Rheumatoid Arthritis
…, K Sitek‐Ziolkowska, M Rell‐Bakalarska… - Arthritis & …, 2018 - Wiley Online Library
Objective SB 5 is a biosimilar agent for adalimumab (ADA). The aim of this study was to
evaluate the efficacy, pharmacokinetics (PK), safety, and immunogenicity of SB 5 in …
evaluate the efficacy, pharmacokinetics (PK), safety, and immunogenicity of SB 5 in …
[PDF][PDF] Oral vs. subcutaneous low-dose methotrexate treatment in reducing gastrointestinal side effects
L Rutkowska-Sak, M Rell-Bakalarska… - Reumatologia …, 2009 - termedia.pl
RU 4 2009:RU 1 2006.qxd.qxd Page 1 Reumatologia 2009; 47/4 Reu ma to lo gia 2009; 47, 4:
207–211 Original paper/Artykuł oryginalny Summary The aim of our present data was to …
207–211 Original paper/Artykuł oryginalny Summary The aim of our present data was to …
Psychological stress in rheumatoid arthritis patients: a comparative Polish–German study: summary of the current conceptualization of the role of stress in rheumatoid …
…, A Sagan, M Konarska, M Rell-Bakalarska… - Autoimmunity …, 2010 - Elsevier
Cultural differences in experiencing individual stress in rheumatoid arthritis (RA) patients
might be observed. The aim of the study was to assess quality of life and psychological …
might be observed. The aim of the study was to assess quality of life and psychological …
Occupational work and quality of life in osteoarthritis patients
…, J Bugajska, A Najmiec, M Rell-Bakalarska… - Rheumatology …, 2006 - Springer
The ageing European population suffers from chronic diseases, including osteoarthritis
(OA). The aim of this study was to investigate the work activity/ability, the quality of life and …
(OA). The aim of this study was to investigate the work activity/ability, the quality of life and …
[PDF][PDF] Withdrawing ixekizumab in patients with psoriatic arthritis who achieved minimal disease activity: results from a randomized, double‐blind withdrawal study
…, R Reddy, D Rekalov, M Rell‐Bakalarska… - Arthritis & …, 2021 - Wiley Online Library
Objective To evaluate the effect of withdrawing ixekizumab in patients with psoriatic arthritis
(PsA) in whom minimal disease activity (MDA) has been achieved after open‐label …
(PsA) in whom minimal disease activity (MDA) has been achieved after open‐label …
Differential association of juvenile and adult systemic lupus erythematosus with genetic variants of oestrogen receptors alpha and beta
…, P Krajewski, J Łącki, M Rell-Bakalarska… - Lupus, 2011 - journals.sagepub.com
Oestrogens acting via nuclear receptors (encoded by ESR1 or ESR2) are important for
pathogenesis of systemic lupus erythematosus (SLE). rs2234693 and rs4986938 are two …
pathogenesis of systemic lupus erythematosus (SLE). rs2234693 and rs4986938 are two …
MRI assessment of early response to certolizumab pegol in rheumatoid arthritis: a randomised, double-blind, placebo-controlled phase IIIb study applying MRI at …
…, JWJ Bijlsma, A Dudek, M Rell-Bakalarska… - Annals of the …, 2015 - ard.bmj.com
Objectives To identify the first time point of an MRI-verified response to certolizumab pegol
(CZP) therapy in patients with rheumatoid arthritis (RA). Methods Forty-one patients with …
(CZP) therapy in patients with rheumatoid arthritis (RA). Methods Forty-one patients with …